ALDX today
$0.61-$0.04 (-6.36%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourBullish
1 hourAscending Triangle
15 minExpanding
5 minStrong Bullish
Daily trend turns up above $0.72
Key levels
Resistance$0.86
Resistance$0.72
Support$0.57
Latest news & SEC filings
LegalAldeyra seeks FDA division change for ADX-2191 PVRL review
All ALDX news →About Aldeyra Therapeutics
This biotech firm focuses on creating treatments for conditions driven by the immune system. Its lead drug candidate, reproxalap, is an eye drop being tested for dry eye and allergic conjunctivitis, while ADX-2191 is an injectable form of methotrexate for two rare retinal diseases. Earlier-stage oral compounds target inflammatory pathways. The company is based in the United States and has no marketed products.
Based on the company's 10-K filed Feb 27, 2026.
Nasdaq · Healthcare
Aldeyra Therapeutics, Inc. (ALDX)
What Is the Price Target for ALDX?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is ALDX a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ALDX.
Start Free Trial →Is ALDX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$1.53
7
Moat Score
NONE
2/9
Piotroski Score
-9.4
Altman Z-Score
What Is Smart Money Doing with ALDX?
Insider Signal
NEUTRAL
3 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Brady Todd C | director officer | Buy | 250,000 | $418K | Jun 3, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ALDX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
40.43%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for ALDX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ALDX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:02:54 | $0.61 | 1,000 | $$607 | SELL |
| 15:02:00 | $0.63 | 25,000 | $$16K | BUY |
| 14:57:15 | $0.61 | 2,500 | $$2K | SELL |
| 23:45:35 | $0.64 | 2,440 | $$2K | SELL |
| 20:59:13 | $0.65 | 3,571 | $$2K | SELL |
5 dark pool trades shown · $$22K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Aldeyra Therapeutics, Inc. (ALDX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ALDX — frequently asked questions
What is ALDX stock price today?
Aldeyra Therapeutics, Inc. (ALDX) is at $0.61, down 6.36% (-$0.04) at the Nov 12, 2026 close.
Why is ALDX stock moving today?
Latest ALDX news — Nov 9, 2026: Aldeyra seeks FDA division change for ADX-2191 PVRL review
What do analysts rate ALDX?
Analyst ratings for ALDX: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did ALDX beat earnings?
ALDX last reported on Aug 6, 2026: EPS -$0.09 vs -$0.09 expected — a miss of 2.9%.
Does ALDX pay a dividend?
ALDX does not currently pay a dividend.
What are ALDX support and resistance levels?
Support: $0.57. Resistance: $0.72, $0.86, $0.99.
What are insiders doing with ALDX?
Insider activity: NEUTRAL, 3 buys and 0 sells in the last 90 days.
What is the latest news on ALDX?
Nov 9, 2026: Aldeyra seeks FDA division change for ADX-2191 PVRL review